focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,372.00
Bid: 1,368.00
Ask: 1,380.00
Change: 44.00 (3.31%)
Spread: 12.00 (0.877%)
Open: 1,360.00
High: 1,394.00
Low: 1,338.00
Prev. Close: 1,372.00
AVON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

29 Apr 2015 07:00

RNS Number : 6149L
Avon Rubber PLC
29 April 2015
 

News ReleaseStrictly embargoed until 07:00 29 April 2015

AVON RUBBER p.l.c.

("Avon", the "Group" or the "Company")

Unaudited interim results for the six months ended 31 March 2015

 

31 March 2015

31 March 2014

Increase

£Millions

£Millions

REVENUE

62.8

61.5

2%

ADJUSTED EBITDA (*)

12.2

11.1

9%

ADJUSTED OPERATING PROFIT (*)

8.5

8.2

4%

ADJUSTED PROFIT BEFORE TAX (*)

8.4

8.0

4%

NET CASH / (DEBT)

7.3

(5.5)

EARNINGS PER SHARE:

Adjusted basic (*)

22.3p

20.4p

9%

Adjusted diluted (*)

21.7p

19.8p

10%

INTERIM DIVIDEND

2.43p

1.87p

30%

 

FINANCIAL HIGHLIGHTS

· 10% earnings per share growth against a very strong comparator period last year

· Continuing strong cash generation increased cash balances to £7.3m in an already strong balance sheet

· 30% increase in interim dividend to 2.43p per share

 

OPERATIONAL HIGHLIGHTS

· Dairy delivered a record half year performance as our investment in routes to market and innovative products and services delivered returns

· Dairy Cluster Exchange service growth of 34% since 30 September 2014

· Encouraging progress in Dairy in China; Brazil sales and distribution operation opened

· Healthy order intake in Protection & Defence of £47m. Closing order book of £38m with £28m for delivery in H2 2015

· Our new Deltair SCBA gained market share in the US Fire market

 

Peter Slabbert, Chief Executive commented:

 "Avon has enjoyed another positive half year, achieving a 10% increase in earnings per share against a very strong comparator period last year that included a 52,000 C50 delivery to a customer in the Middle East.

Trading is normally second-half weighted in our Protection & Defence business and we believe this will continue to be the case this year. We have a strong forward order book in Protection & Defence and believe that the momentum in Dairy will continue.

The Board therefore expects to make good progress as the year develops and to meet market expectations for the full year."

(*) Note:

The Directors believe that adjusted measures provide a more useful comparison of business trends and performance. Adjusted results exclude exceptional items, defined benefit pension scheme costs and the amortisation of acquired intangibles. The term adjusted is not defined under IFRS and may not be comparable with similarly-titled measures used by other companies.

All profit and earnings per share figures in these interim results relate to adjusted business performance (as defined above) unless otherwise stated. A reconciliation of adjusted measures to non-adjusted measures is provided below:

Statutory

Adjustments

Adjusted

Group EBITDA (£m)

12.7

(0.5)

12.2

Group operating profit (£m)

8.9

(0.4)

8.5

Other finance expense (£m)

0.4

(0.3)

0.1

Basic earnings per share (pence)

22.4

(0.1)

22.3

Diluted earnings per share (pence)

21.8

(0.1)

21.7

Protection & Defence operating profit (£m)

6.2

0.1

6.3

The adjustments comprise:

· amortisation of acquired intangibles of £0.1m

· defined benefit pension scheme costs which relate to a scheme closed to future accrual and therefore do not relate to current operations:

o Administrative expenses of £0.2m

o Settlement gain of £0.7m following a trivial commutation exercise

o Other finance expense of £0.3m

 

Avon Rubber p.l.c.

Weber Shandwick Financial

Peter Slabbert, Chief Executive: 020 7067 0000

Nick Oborne: 020 7067 0000

Andrew Lewis, Group Finance Director: 01225 896 830

 

Sarah Matthews-DeMers, Group Financial Controller: 01225 896 835

 

Jo Wotton, Public Relations Manager: 01225 896 563

 

 

An analyst meeting will be held at 9.30am this morning at the offices of Weber Shandwick Financial, 2 Waterhouse Square, 140 Holborn, London, EC1N 2AE.

 

NOTES TO EDITORS:

The Group has transformed itself over recent years into an innovative design and engineering group specialising in two core markets, Protection & Defence and Dairy. With a strong emphasis on research and development we design, test and manufacture specialist products from a number of sites in the US and UK, serving markets around the world. We achieve this through nurturing the talent and aspirations of our employees to realise their highest potential.

 

Avon Protection is the recognised global market leader in advanced Chemical, Biological, Radiological and Nuclear (CBRN) respiratory protection systems technology for the world's military, homeland security, first responder, fire and industrial markets. With an unrivalled pedigree in mask design dating back to the 1920's, Avon Protection's advanced products are the first choice for Personal Protective Equipment (PPE) users worldwide and are placed at the heart of many international defence and tactical PPE deployment strategies. Our expanding global customer base now includes military forces, civil and first line defence troops, emergency service teams and industrial, marine, mineral and oil extraction site personnel. All put their trust in Avon's advanced respiratory solutions to shield them from every possible threat.

 

Our world-leading Dairy supplies business and its Milkrite brand have a global market presence. With a long history of manufacturing liners and tubing for the dairy industry, we have become the leading innovator and designer for products and services right at the heart of milking. Our goal is always to improve and maintain animal health. Working with the leading scientists and health specialists in the global dairy industry we continue to invest in technology to further improve the milking process and animal welfare. Our products provide exceptional results for both the animal and the milker, making the milk extraction process run smoothly. As our market share and milking experience continue to improve, so does our global presence.

 

For further information please visit the Group's website: www.avon-rubber.com

 

Interim Management Report

Introduction

 

Avon has enjoyed another positive half year with a 10% increase in earnings per share against a very strong comparator period last year. Our Dairy division returned record results as our strategy of product and service innovation and geographic expansion continues to deliver success. In Protection & Defence revenues for the half year were, as planned, weighted towards US Department of Defense (DOD) sales under our 10 year sole source contract and gross margins were, as a consequence, lower than in the record prior period. Despite this, net margins for the division increased, continuing the long-term trend of improvement. We have also made encouraging progress in generating opportunities in the North American Fire market and in the Middle East which are likely to be realised in the second half.

Group Results

 

Group revenue at £62.8m (2014: £61.5m) increased by 2% and operating profit of £8.5m (2014: £8.2m) increased by 4%. Earnings before interest, tax, depreciation and amortisation ('EBITDA') increased by 9% to £12.2m (2014: £11.1m) representing a return on sales (defined as EBITDA divided by revenue) of 19.4% (2014: 18.1%).

The impact of foreign exchange translation was a slight tailwind of £0.4m as the $/£ average rate of $1.54 was lower than the $1.63 prevailing in the same period last year. This translation benefit has been offset by transactional losses, where the weakening Euro together with US dollar transactions covered by forward contracts at rates higher than the average rate have given rise to mark to market foreign exchange losses of £0.3m in the period.

If the currently stronger US dollar were to prevail throughout the remainder of the financial year, it would create further translation tailwinds for the full year. Our sensitivity analysis on the full year 2014 results showed that a 5c movement in the $/£ exchange rate would result in a £0.4m impact on annual operating profit.

Profit before tax was £8.4m (2014: £8.0m) and after a tax charge of £1.7m (2014: £1.9m), an effective rate of 20% (2014: 24%), the Group recorded a profit for the period after tax of £6.7m (2014: £6.1m). The reduced tax rate reflects the anticipated geographic split of taxable profits for 2015. Basic earnings per share were up 9% at 22.3p (2014: 20.4p) and fully diluted earnings per share were up 10% at 21.7p (2014: 19.8p).

 

Net Debt and Cashflow

Net cash at the half year was £7.3m, up from £2.9m at the 2014 year end, which had benefitted from early payments from certain customers.

 

Operating cash conversion remained strong at 138% of operating profit. Turning profits into cash has enabled us to continue to invest in the future of the business with £3.1m of capital investment, while, at the same time, increasing dividends to shareholders by 30%.

 

Total bank facilities at 31 March 2015 were $40m. These facilities are committed until 30 November 2017.

 

Protection & Defence

 

Performance

 

Revenue for the division was £45.3m (2014: £45.6m) and operating profit was £6.4m (2014: £6.8m). The decrease was expected and arose from the mix of product shipped in the period being heavily DOD biased, whereas the comparable period had a heavy non-DOD weighting. As we have always said, while predicting the timing of non-DOD orders and sales is difficult, our long-term DOD contract and manufacturing excellence affords us the flexibility to fulfil non-DOD orders as and when they arise and to meet the DOD's demand in periods when non- DOD orders are lower.

 

EBITDA was up 1% at £9.4m (2014: £9.2m) as the effect of the change in mix towards DOD sales was more than offset by cost savings following the consolidation of our US sites, increases in sales to Fire customers as our new Deltair product gained traction and AEF enjoying another successful period. Return on sales, as defined above, was 21% (2014: 20%).

 

Markets

 

M50 respirator sales to the DOD were, as expected, significantly higher in the first half of the year at 112,000 (2014: 58,000) mask systems. During the period we received a further order for 160,000 mask systems which means we exit the half year with mask order coverage well into 2016, providing good visibility of revenue under this sole source long-term contract.

 

We did not deliver any M61 filters during the period (2014: 162,000 pairs). We understand that the second source has successfully qualified its filter and has fulfilled its first order. In the long term, we believe the end user demand for this consumable product will grow as fielding of the mask accelerates but we continue to recognise that, in the current DOD procurement environment, obtaining short-term visibility of future filter orders remains challenging. However, we do expect to see some further filter requirements later this year.

 

Since the comparable period last year included delivery of the 52,000 C50 order, as expected, sales to foreign military, law enforcement and first responder customers reduced year on year. However, during the period we have been encouraged by the level of international enquiries for our respiratory protection products and, although the timing of converting some of the larger opportunities has not fallen into the first half, we are encouraged that the underlying pipeline of individually smaller sales opportunities has grown and we have a number of opportunities that leave us well placed to deliver a richer mix of sales in the second half of the year.

 

We saw strong growth in sales to the North American Fire market this period following the release of our new NFPA-approved Deltair SCBA. Our product, which is designed to meet the new US regulations and to deliver enhanced operational performance, has been well received by the market and remains one of only four units to receive approval to date. The product procurement cycle in the Fire market is longer than in the Law Enforcement market due to trial and evaluation processes and the level of enquires and continuing customer trials gives us confidence that this product has the opportunity to enhance our market share further.

 

Other DOD spares sales were lower than the same period last year reflecting normal variability in the timing of orders and delivery schedules. Order intake for spares has however been positive and thus we expect higher levels of revenue in this area in the second half. Our industrial escape product, launched in 2014, has continued to be well received in oil and gas markets. AEF has seen a continuation of the high level of order intake experienced last year and has contributed positively again this period.

 

Order intake for the first half totalled £47m. Of the closing order book of £38m, £28m is for delivery in the second half of our financial year giving good visibility for the remainder of the year.

 

Opportunities

 

Our funded development programme with the US Air Force to design and test the MM53 Joint Service Aircrew Mask (JSAM) has progressed well with the prototype product passing the customer's critical design review during the period. The customer has also confirmed that it has budget monies allocated to the production phase of the programme and that it expects this to commence in 2017.

 

Our Emergency Escape Breathing Device (EEBD) received NIOSH approval late in 2014. In December 2014 we responded to a US Navy solicitation to supply EEBDs to replace its existing fielded product. We have not yet received a response from the US Navy to this solicitation but expect to hear during the second half of the year.

 

Dairy

Performance

 

Revenue for the Dairy business was 10% higher at £17.5m (2014: £15.9m) as we grew in all of our markets, supplemented by the positive translation effect of the stronger US dollar. An increasing proportion of higher-margin Milkrite product and service sales contributed to an increased operating profit of £3.3m (2014: £2.7m). Return on sales, as defined above, increased to 22% (2014: 20%).

 

Markets

 

Market conditions have been positive during the period. In global markets, milk prices have remained at acceptable levels and farmer input costs have been favourable meaning there has been less pressure on farmer revenues and margins and therefore normal levels of demand for our consumable products.

 

In Europe, Milkrite's market share has increased as a result of our increased sales force, enhanced technical support and a larger distributor network. Our Impulse Air mouthpiece vented liner, first launched in Europe late in 2013, continues to gain traction, with its market share increasing to 3.0% (31 March 2014: 2.0%, 30 September 2014: 2.6%).

 

In the US, the Milkrite Impulse Air mouthpiece vented liner continued to perform well, with its market share increasing to 22% (31 March 2014: 20%, 30 September 2014: 21%).

 

Our Cluster Exchange service was launched in the US and Europe in 2014 and growth rates are now exceeding our expectations. By the end of the period it was servicing 342,000 cows on 1,100 farms in the US and Europe. This added-value service enhances the value of each direct liner sale we make and should lead to a more robust and sustainable business model.

 

In China, year on year revenue grew strongly against a weak comparator period. The industrialisation of the milking process continues apace, creating excellent long-term potential for our consumable products.

 

Opportunities

 

In many other emerging markets, including Brazil and India, the number of dairy cows being milked using automated milking processes is growing rapidly. This is adding to the market potential for the products we sell. We opened a sales and distribution centre in

 

Brazil in the period to service Brazil and the wider South American market. Our first sales were made late in the period and we expect a full period of trading in the second half of our financial year. As with any start up, we expect this to be a short-term drag on divisional profit growth but our target for this operation is to make a positive contribution to profit in 2017.

 

Retirement Benefit Obligations

 

The IAS 19R valuation of the Group's UK retirement benefit obligations has moved from a deficit of £16.0m at 30 September 2014 to a reduced deficit of £15.6m at 31 March 2015. This arose from a strong asset performance from our return-seeking assets offset by a fall in AA corporate bond rates which increased liabilities.

During the period the Group made cash contributions in respect of deficit recovery payments and administration costs of £275,000 (2014: £237,000).

The last actuarial valuation undertaken as at 31 March 2013 showed the scheme to be 98.0% funded.

 

Dividends

 

The final dividend for the 2014 financial year of 3.74p per ordinary share was paid to shareholders on 20 March 2015 and absorbed £1,127,000 of shareholders' funds.

 

Following the period end, the Board has declared an interim dividend of 2.43p per ordinary share for 2015, an increase of 30% on the 2014 interim dividend. This will be paid on 4 September 2015 to shareholders on the register on 7 August 2015. It is expected to absorb £732,000 of shareholders' funds and there are no corporation tax consequences.

 

Board Changes

 

The Board is separately announcing today that Peter Slabbert has informed the Board of his intention to step down from his role as Chief Executive and retire from the Company.

This change will become effective 30 September 2015. The search for a successor has already commenced.

 

Outlook

The Board remains confident that the Group will continue to deliver organic growth in this financial year in line with current market expectations and that our strong cash generation and balance sheet will allow us to invest in future growth opportunities.

 

As is usual, we expect a second half bias to the financial performance of our Protection & Defence business. Although the timing of receipt of orders remains difficult to predict, the DOD order we received late in the first half and our sales pipeline of other opportunities give us confidence that Protection & Defence will make further progress in the second half of this year.

 

In Dairy, the business has good momentum with our high technology differentiated products and services gaining market share. This, together with the sales and distribution platforms we have established in China and Brazil to service the rapidly growing emerging markets, means we have a Dairy business with excellent short and longer term growth prospects.

 

Peter SlabbertChief Executive

29 April 2015

Andrew LewisGroup Finance Director29 April 2015

 

Statement of Directors' Responsibilities

 

The Directors confirm that this condensed consolidated interim financial information has been prepared in accordance with the International Accounting Standard 34, 'Interim Financial Reporting' as adopted by the European Union, and that the interim management report herein includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8, namely:

 

an indication of important events that have occurred during the first six months and their impact on the condensed consolidated interim financial information, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and

 

material related party transactions in the first six months and any material changes in the related‐party transactions described in the last annual report

The Directors are as listed on page 41 of the 2014 Annual Report, except that Stella Pirie retired from the Board on 29 January 2015 and Pim Vervaat was appointed on 1 March 2015.

 

Forward‐looking statementsCertain statements in this half year report are forward‐looking. Although the Group believes that the expectations reflected in these forward‐looking statements are reasonable, we can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward‐looking statements.

 

We undertake no obligation to update any forward‐looking statements whether as a result of new information, future events or otherwise.

 

Company website

 

The interim statement is available on the Company's website at www.avon‐rubber.com. The maintenance and integrity of the website is the responsibility of the Directors. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

 

Miles Ingrey-CounterCompany Secretary29 April 2015

 

Consolidated Statement of Comprehensive Income

Half year to 31 March 2015

Half year to 31 March 2014

Year to 30 Sep 2014

Statutory

Adjustments

Adjusted

Statutory

Adjustments

Adjusted

Statutory

Adjustments

Adjusted

Note

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Revenue

4

62,821

-

62,821

61,491

-

61,491

124,779

-

124,779

Cost of sales

(41,389)

-

(41,389)

(40,718)

-

(40,718)

(83,264)

-

(83,264)

Gross profit

21,432

-

21,432

20,773

-

20,773

41,515

-

41,515

Selling and distribution costs

(6,984)

-

(6,984)

(4,894)

-

(4,894)

(11,505)

-

(11,505)

General and administrative expenses

(5,540)

(363)

(5,903)

(9,983)

2,330

(7,653)

(15,685)

2,678

(13,007)

Operating profit

4

8,908

(363)

8,545

5,896

2,330

8,226

14,325

2,678

17,003

Operating profit is analysed as:

Before depreciation and amortisation

12,662

(493)

12,169

8,933

2,200

11,133

20,486

2,417

22,903

Depreciation and amortisation

(3,754)

130

(3,624)

(3,037)

130

(2,907)

(6,161)

261

(5,900)

Operating profit

8,908

(363)

8,545

5,896

2,330

8,226

14,325

2,678

17,003

Finance income

6

9

-

9

-

-

-

1

-

1

Finance costs

6

(51)

-

(51)

(103)

-

(103)

(275)

-

(275)

Other finance expense

6

(453)

329

(124)

(97)

6

(91)

(187)

12

(175)

Profit before taxation

8,413

(34)

8,379

5,696

2,336

8,032

13,864

2,690

16,554

Taxation

7

(1,683)

-

(1,683)

(1,590)

(350)

(1,940)

(3,053)

(450)

(3,503)

Profit for the period

6,730

(34)

6,696

4,106

1,986

6,092

10,811

2,240

13,051

Consolidated Statement of Comprehensive Income (continued)

 

Half year to 31 March 2015

Half year to 31 March 2014

Year to 30 Sep 2014

Statutory

Adjustments

Adjusted

Statutory

Adjustments

Adjusted

Statutory

Adjustments

Adjusted

Note

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Other comprehensive income/(expense)

Actuarial gain/(loss) recognised in retirement benefit scheme (*)

22

-

22

5,446

-

5,446

(4,851)

-

(4,851)

Net exchange differences offset in reserves (**)

3,008

 

 -

3,008

(1,147)

-

(1,147)

(306)

-

(306)

Other comprehensive income/(expense) for the period, net of taxation

3,030

-

3,030

4,299

-

4,299

(5,157)

-

(5,157)

Total comprehensive income for the period

9,760

(34)

9,726

8,405

1,986

10,391

5,654

2,240

7,894

Earnings per share

Basic

9

22.4

22.3

13.8p

20.4p

36.2p

43.7p

Diluted

9

21.8

21.7

13.3p

19.8p

35.0p

42.3p

 

* Items that are not subsequently reclassified to the income statement

**Items that may be subsequently reclassified to the income statement

 

Consolidated Balance Sheet

As at

As at

As at

31 Mar 15

31 Mar 14

30 Sep 14

Note

£'000

£'000

£'000

Assets

Non-current assets

Intangible assets

19,011

16,317

17,240

Property, plant and equipment

20,249

19,832

19,575

39,260

36,149

36,815

Current assets

Inventories

16,722

15,431

12,887

Trade and other receivables

15,630

16,276

19,157

Derivative financial instruments

-

137

2

Cash and cash equivalents

13

7,273

217

2,925

39,625

32,061

34,971

Liabilities

Current liabilities

Trade and other payables

17,947

15,236

17,755

Derivative financial instruments

284

-

-

Provisions for liabilities and charges

10

689

1,830

1,846

Current tax liabilities

7,711

6,158

6,852

26,631

23,224

26,453

Net current assets

12,994

8,837

8,518

Non-current liabilities

Borrowings

13

-

5,755

-

Deferred tax liabilities

2,716

2,481

2,315

Retirement benefit obligations

15,568

5,802

16,029

Provisions for liabilities and charges

10

1,241

2,659

1,973

19,525

16,697

20,317

Net assets

32,729

28,289

25,016

Shareholders' equity

Ordinary shares

11

31,023

31,023

31,023

Share premium account

11

34,708

34,708

34,708

Capital redemption reserve

500

500

500

Translation reserve

2,076

(1,773)

(932)

Accumulated losses

(35,578)

(36,169)

(40,283)

Total equity

32,729

28,289

25,016

 

 

 

 

 

 

 

Consolidated Cash Flow Statement

Half year to

Half year to

Year to

31 Mar 15

31 Mar 14

30 Sep 14

Note

£'000

£'000

£'000

Cash flows from operating activities

Cash generated before the impact of exceptional items

11,828

11,302

26,500

Cash impact of exceptional items

(694)

-

(983)

Cash generated from operations

12

11,134

11,302

25,517

Finance income received

9

-

1

Finance costs paid

(51)

(101)

(315)

Retirement benefit deficit recovery contributions

(275)

(237)

(513)

Tax paid

(1,232)

(1,778)

(2,903)

Net cash generated from operating activities

9,585

9,186

21,787

Cash flows from investing activities

Proceeds from sale of property, plant and equipment

-

17

19

Purchase of property, plant and equipment

(1,411)

(1,893)

(3,753)

Capitalised development costs and software

(1,733)

(1,265)

(3,062)

Acquisition of VR Technology Holdings

(25)

-

(50)

Net cash used in investing activities

(3,169)

(3,141)

(6,846)

Cash flows from financing activities

Net movements in loans

-

(5,149)

(10,805)

Dividends paid to shareholders

(1,127)

(862)

(1,422)

Purchase of own shares

(1,152)

-

-

Net cash used in financing activities

(2,279)

(6,011)

(12,227)

Net increase in cash, cash equivalents and bank overdrafts

4,137

34

2,714

Cash, cash equivalents and bank overdrafts at beginning of the year

2,925

184

184

Effects of exchange rate changes

211

(1)

27

Cash, cash equivalents and bank overdrafts at end of the period

13

 

7,273

217

2,925

 

Consolidated Statement of Changes in Equity

Share

Share

Other

Accumulated

capital

Premium

reserves

losses

Total

Note

£'000

£'000

£'000

£'000

£'000

At 30 September 2013

30,723

34,708

(126)

(44,609)

20,696

Profit for the period

-

-

-

4,106

4,106

Unrealised exchange differences on overseas investments

-

-

(1,147)

-

(1,147)

Actuarial gain recognised in retirement benefit scheme

-

-

-

5,446

5,446

Total comprehensive income for the period

-

-

(1,147)

9,552

8,405

Dividends paid

-

-

-

(862)

(862)

Issue of shares

300

-

-

-

300

Purchase of shares by the employee benefit trust

-

-

-

(300)

(300)

Movement in respect of employee share schemes

-

-

-

50

50

At 31 March 2014

31,023

34,708

(1,273)

(36,169)

28,289

Profit for the period

-

-

-

6,705

6,705

Unrealised exchange differences on overseas investments

-

-

841

-

841

Actuarial loss recognised in retirement benefit scheme

-

-

-

(10,297)

(10,297)

Total comprehensive expense for the period

-

-

841

(3,592)

(2,751)

Dividends paid

8

-

-

-

(560)

(560)

Movement in respect of employee share schemes

-

-

-

38

38

At 30 September 2014

31,023

34,708

(432)

(40,283)

25,016

Profit for the period

-

-

-

6,730

6,730

Unrealised exchange differences on overseas investments

-

-

3,008

-

3,008

Actuarial gain recognised in retirement benefit scheme

-

-

-

22

22

Total comprehensive income for the period

-

-

3,008

6,752

9,760

Dividends paid

8

-

-

-

(1,127)

(1,127)

Movement in shares held by the employee benefit trust

11

-

-

-

(962)

(962)

Movement in respect of employee share schemes

-

-

-

42

42

At 31 March 2015

31,023

34,708

2,576

(35,578)

32,729

 

Notes to the Interim Financial Statements

 

1. General information

 

The company is a limited liability company incorporated in England and domiciled in the UK. The address of its registered office is Hampton Park West, Semington Road, Melksham, Wiltshire, SN12 6NB. The company has its primary listing on the London Stock Exchange.

 

This unaudited condensed consolidated interim financial information was approved for issue on 29 April 2015.

 

These interim financial results do not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 30 September 2014 were approved by the Board of Directors on 19 November 2014 and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under Section 498 of the Companies Act 2006.

 

2. Basis of preparation

 

This condensed consolidated interim financial information for the half year ended 31 March 2015 has been prepared in accordance with the Disclosure and Transparency Rules of the Financial Services Authority and with IAS 34, 'Interim financial reporting' as adopted by the European Union. These interim financial results should be read in conjunction with the annual financial statements for the year ended 30 September 2014, which have been prepared in accordance with IFRSs as adopted by the European Union.

 

Having considered the Group's funding position, budgets for 2015 and three year plan, the Directors have formed a judgment that there is a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. For this reason the Directors continue to adopt the going concern basis in preparing the condensed consolidated interim financial information.

 

3. Accounting policies

 

The accounting policies adopted are consistent with those of the annual financial statements for the year ended 30 September 2014, as described in those financial statements, except as described below. For the period ended 31 March 2014 , the classification of overhead costs between selling and distribution costs and general and administrative expenses has been represented to provide more relevant information. There is no impact on operating profit.

 

Recent accounting developments

 

The following standards, amendments and interpretations have been issued by the International Accounting Standards Board (IASB) or by the International Financial Reporting Interpretations Committee (IFRIC). The Group's approach to these is as follows:

a) Standards, amendments and interpretations effective in 2015

The following standards and amendments have been adopted in preparing the condensed consolidated half-yearly financial information and will be adopted for the year ending 30 September 2015 but have no impact on the interim financial information:

 

- IAS 32, 'Offsetting Financial Assets and Financial Liabilities'

- IAS 36, 'Recoverable Amount Disclosures for Non-Financial Assets'

- IAS 39, 'Novation of Derivatives and Continuation of Hedge Accounting'

- IFRIC 21, 'Levies'

- Amendments to IFRS 10, IFRS 12 and IAS 27, 'Investment Entities'

- Amendments to IAS 19, 'Defined Benefit Plans: Employee Contributions'

- Annual improvements cycle 2010-2012

- Annual improvements cycle 2011-2013

 

 

b) Standards, amendments and interpretations to existing standards issued but not yet effective in 2015 and not adopted early:

 

- IFRS 9, 'Financial instruments'

- IFRS 14, 'Regulatory Deferral Accounts'

- IFRS 15, 'Revenue from Customer Contracts'

- Amendments to IAS 1, 'Disclosure initiative'

- Amendment to IFRS 10 and IAS 28, 'Sale or Contribution of Assets between and Investor and its Associate or Joint Venture'

- Amendments to IFRS 10, IFRS 12 and IAS 28, 'Applying the consolidation exemption'

- Amendments to IFRS 11, 'Accounting for Acquisition Interests in Joint Operations'

- Amendments to IAS 16 and IAS 38, 'Clarification of Acceptable Methods of Depreciation and Amortisation'

- Amendments to IAS 16 and IAS 41, 'Agriculture - Bearer Plants'

- Amendments to IAS 27, 'Equity Method in Separate Financial Statements'

- Annual improvements cycle 2012-2014

4. Segment information

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Group Executive team.

 

 

 

The Group has two clearly defined business segments, Protection & Defence and Dairy, and operates out of the UK and the US.

 

 

Business segments

 

Half year to 31 March 2015

 

Protection & Defence

 

Dairy

Unallocated

Group

 

£'000

£'000

£'000

£'000

 

Revenue

45,333

17,488

62,821

 

 

Segment result before depreciation, amortisation and defined benefit pension scheme credit

9,358

3,872

(1,061)

12,169

 

Depreciation of property, plant and equipment

(1,724)

(533)

(26)

(2,283)

 

Amortisation of intangibles

(1,275)

(61)

(5)

(1,341)

 

Segment result before amortisation of acquired intangibles and defined benefit pension scheme credit

6,359

3,278

(1,092)

8,545

 

Amortisation of acquired intangibles

(130)

(130)

 

Defined benefit pension scheme credit

493

493

 

Segment result

6,229

3,278

(599)

8,908

 

Finance costs

(42)

(42)

 

Other finance expense

(453)

(453)

 

Profit before taxation

6,229

3,278

(1,094)

8,413

 

Taxation

(1,683)

(1,683)

 

Profit for the period

6,229

3,278

(2,777)

6,730

 

 

 

Half year to 31 March 2014

Protection & Defence

Dairy

Unallocated

Group

£'000

£'000

£'000

£'000

Revenue

45,639

15,852

61,491

Segment result before depreciation, amortisation, exceptional items and defined benefit pension scheme costs

9,237

3,176

(1,280)

11,133

Depreciation of property, plant and equipment

(1,597)

(382)

(30)

(2,009)

Amortisation of intangibles

(837)

(57)

(4)

(898)

Segment result before amortisation of acquired intangibles, exceptional items and defined benefit pension scheme costs

6,803

2,737

(1,314)

8,226

Amortisation of acquired intangibles

(130)

(130)

Exceptional items

(2,000)

(2,000)

Defined benefit pension scheme costs

(200)

(200)

Segment result

4,673

2,737

(1,514)

5,896

Finance costs

(103)

(103)

Other finance expense

(97)

(97)

Profit before taxation

4,673

2,737

(1,714)

5,696

Taxation

(1,590)

(1,590)

Profit for the period

4,673

2,737

(3,304)

4,106

 

Year to 30 September 2014

Protection & Defence

Dairy

Unallocated

Group

£'000

£'000

£'000

£'000

Revenue

92,818

31,961

124,779

Segment result before depreciation, amortisation, exceptional items and defined benefit pension scheme costs

18,542

6,600

(2,239)

22,903

Depreciation of property, plant and equipment

(3,289)

(771)

(67)

(4,127)

Amortisation of intangibles

(1,670)

(94)

(9)

(1,773)

Segment result before amortisation of acquired intangibles, exceptional items and defined benefit pension scheme costs

13,583

5,735

(2,315)

17,003

Amortisation of acquired intangibles

(261)

(261)

Exceptional items

(2,017)

(2,017)

Defined benefit pension scheme costs

(400)

(400)

Segment result

11,305

5,735

(2,715)

14,325

Finance income

1

1

Finance costs

(275)

(275)

Other finance expense

(187)

(187)

Profit before taxation

11,305

5,735

(3,176)

13,864

Taxation

(3,053)

(3,053)

Profit for the year

11,305

5,735

(6,229)

10,811

 

Revenue by origin

Half year to

Half year to

Year to

31 Mar 15

31 Mar 14

30 Sep 14

£'000

£'000

£'000

UK

11,819

14,725

23,508

US

51,002

46,766

101,271

62,821

61,491

124,779

Segment assets in the UK and US were £17.3m and £61.6m respectively (30 September 2014: £14.0m and £57.8m, 31 March 2014: £12.9m and £55.3m).

 

5. Amortisation of acquired intangibles, exceptional items and defined benefit pension scheme costs

Half year to

Half year to

Year to

31 Mar 15

31 Mar 14

30 Sep 14

£'000

£'000

£'000

Amortisation of acquired intangible assets

130

130

261

 

 

Exceptional items

£'000

£'000

£'000

Relocation of Lawrenceville facility

-

2,000

2,017

-

2,000

2,017

 

The tax impact of the above is a £nil reduction in overseas tax payable (31 March 2014: £0.35m, 30 September 2014: £0.45m).

The statutory results have also been adjusted to exclude items in relation to the defined benefit pension scheme as this is closed to future accrual and therefore does not relate to current operations. The adjustments comprise:

o Administrative expenses of £0.2m

o Settlement gain of £0.7m following a trivial commutation exercise

o Other finance expense of £0.3m

6. Finance income and costs

 

Half year to

Half year to

Year to

 

31 Mar 15

31 Mar 14

30 Sep 14

 

£'000

£'000

£'000

 

Interest payable on bank loans and overdrafts

51

103

275

 

Finance income

(9)

(1)

 

42

103 

274

 

 

 

Other finance expense

 

Half year to

Half year to

Year to

 

31 Mar 15

31 Mar 14

30 Sep 14

 

£'000

£'000

£'000

 

Net interest cost: UK defined benefit pension scheme

329

6

12

 

Provisions: Unwinding of discount

124

91

175

 

453

97

187

 

7. Taxation

Half year to

Half year to

Year to

31 Mar 15

31 Mar 14

30 Sep 14

£'000

£'000

£'000

United Kingdom

-

 -

-

Overseas

1,683

1,590

3,053

1,683

1,590

3,053

Effect of exceptional items

-

350

450

Adjusted tax charge

1,683

1,940

3,503

 

The statutory effective tax rate for the period is 20% (31 March 2014: 28%, 30 September 2014: 22%).

 

The adjusted effective tax rate, where the tax charge and the profit before taxation are adjusted for exceptional items, the amortisation of acquired intangibles and defined benefit pension scheme charges is 20% (31 March 2014: 24%, 30 September 2014: 21%).

8. Dividends

On 29 January 2015, the shareholders approved a final dividend of 3.74p per qualifying ordinary share in respect of the year ended 30 September 2014. This was paid on 20 March 2015 absorbing £1,127,000 of shareholders' funds.

 

The Board of Directors has declared an interim dividend of 2.43p (2014: 1.87p) per qualifying ordinary share in respect of the year ended 30 September 2015. This will be paid on 4 September 2015 to shareholders on the register at the close of business on 7 August 2015. In accordance with accounting standards this dividend has not been provided for and there are no corporation tax consequences. It will be recognised in shareholders' funds in the year to 30 September 2015 and is expected to absorb £732,000 (2014: £560,000) of shareholders' funds.

 

9. Earnings per share

Basic earnings per share is based on a profit attributable to ordinary shareholders of £6,730,000 (2014: £4,106,000) and 30,077,000 (2014: 29,800,000) ordinary shares being the weighted average number of shares in issue during the period.

Adjusted earnings per share is based on a profit attributable to ordinary shareholders of £6,696,000 (2014: £6,092,000) after adding back amortisation of acquired intangible assets, exceptional items and defined benefit pension scheme costs.

The Company has 824,000 (2.7%) (2014: 953,000 (3.2%)) potentially dilutive ordinary shares in respect of the Performance Share Plan.

 

10. Provisions for liabilities and charges

 

Facility

Property

 

relocation

obligations

Total

 

 £'000

£'000

£'000

 

Balance at 30 September 2014

454

3,365

3,819

 

Payments in the period

(471)

(1,578)

(2,049)

 

Unwinding of discount

-

124

124

 

Exchange difference

17

19

36

 

Balance at 31 March 2015

-

1,930

1,930

 

 

 

11. Share capital

 

Half year to

Half year to

Year to

 

31 Mar 15

31 Mar 14

30 Sep 14

 

 

Number of shares (thousands)

31,023

31,023

31,023

 

 

Ordinary shares (£'000)

31,023

31,023

31,023

 

 

Share premium (£'000)

34,708

34,708

34,708

 

 

 

During the period 162,095 ordinary shares with a nominal value of £1 each were purchased by the Avon Rubber p.l.c. Employer Share Ownership Trust at a cost of £1,152,000 and 29,459 ordinary shares of £1 each were issued in relation to the 2014 annual incentive plan.

12. Cash generated from operations

Half year to

Half year to

Year to

31 Mar 15

31 Mar 14

30 Sep 14

£'000

£'000

£'000

Profit for the period

6,730

4,106

10,811

Adjustments for:

Taxation

1,683

1,590

3,053

Depreciation

2,283

2,009

4,127

Amortisation of intangible assets

1,471

1,028

2,034

Defined benefit pension scheme (credit)/costs

(493)

200

400

Net finance expense

42

103

274

Other finance expense

453

97

187

Loss on disposal of intangible assets and property, plant and equipment

-

-

358

Movements in working capital and provisions

(1,077)

2,119

4,185

Other movements

42

50

88

11,134

11,302

25,517

 

13. Analysis of net cash

As at

Exchange

As at

30 Sep 14

Cash flow

movements

31 Mar 15

£'000

£'000

£'000

£'000

Cash at bank and in hand

2,925

4,137

211

7,273

Cash and cash equivalents

2,925

4,137

211

7,273

 

 

 

Borrowing facilities

As at

As at

As at

31 Mar 15

31 Mar 14

30 Sep 14

£'000

£'000

£'000

Total undrawn committed facilities

26,521

17,247

24,191

Bank loans and overdrafts utilised

-

5,755

-

Utilised in respect of guarantees

370

330

337

Total Group facilities

26,891

23,332

24,528

The above facilities are with Barclays Bank and Comerica Bank. The combined facility comprises a revolving credit facility of $40m and expires on 30 November 2017. This facility is priced on the US dollar LIBOR plus margin of 1.25% and includes financial covenants which are measured on a quarterly basis. The Group was in compliance with its financial covenants during 2015 and 2014.

14. Exchange rates

 

 

The following significant exchange rates applied during the period.

 

 

Averagerate

Closing rate

Average rate

Closing rate

Average rate

Closing rate

 

H1 2015

H1 2015

H1 2014

H1 2014

FY 2014

FY 2014

 

US dollar

1.539

1.488

1.633

1.664

1.654

1.631

 

Euro

1.309

1.370

1.198

1.210

1.221

1.281

 

 

 

 

 

Fair value of financial instruments

The fair value of forward exchange contracts is determined by using valuation techniques using period end spot rates, adjusted for the forward points to the value date of the contract.

 

15. Principal risks and uncertainties

The principal risks and uncertainties impacting the Group are described on pages 28-31 of our Annual Report 2014 and remain unchanged at 31 March 2015.

 

They include: product development, market threat, business interruption - supply chain, quality risks and product recall, customer dependency, talent management and non-compliance with legislation.

CORPORATE INFORMATION

REGISTERED OFFICECorporate HeadquartersHampton Park WestSemington RoadMelkshamWiltshireSN12 6NBRegistered in England and Wales No. 32965V.A.T. No. GB 137 575 643

BOARD OF DIRECTORSDavid Evans (Chairman)Pim Vervaat (Non-Executive Director)Richard Wood (Non-Executive Director)Peter Slabbert (Chief Executive)Andrew Lewis (Group Finance Director)

COMPANY SECRETARYMiles Ingrey-Counter

INDEPENDENT AUDITORSPricewaterhouseCoopers LLP

REGISTRARS & TRANSFER OFFICECapita Asset ServicesThe Registry34 Beckenham RoadBeckenhamBR3 4TUTel: 0871 664 0300(calls cost 10p per minute plus network extras,lines are open 8.30am-5.30pm Mon-Fri)

BROKERSArden Partners plc

SOLICITORSTLT LLP

PRINCIPAL BANKERSBarclays Bank PLCComerica Inc.

CORPORATE FINANCIAL ADVISER

Arden Partners plc

CORPORATE WEBSITEwww.avon-rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SEUFWAFISEDL
Date   Source Headline
21st May 20247:04 amRNSInterim Results
9th May 20247:00 amRNSUK MoD General Service Respirator order
8th May 202410:00 amRNSDirectors'/PDMR Shareholdings
3rd May 20248:34 amRNSHolding(s) in Company
18th Apr 20241:00 pmRNSHolding(s) in Company
8th Apr 202411:00 amRNSDirectors'/PDMR Shareholdings
5th Apr 20247:00 amRNSHolding(s) in Company
25th Mar 20244:30 pmRNSDirector/PDMR Shareholding
14th Mar 20249:17 amRNSAppointment of Non-Executive Director
6th Mar 20244:17 pmRNSDirectors'/PDMR Shareholdings
20th Feb 20245:00 pmRNSFinal Dividend Currency Exchange Rate
13th Feb 20247:00 amRNSHolding(s) in Company
8th Feb 20247:00 amRNSCapital Markets Event
6th Feb 202410:00 amRNSDirectors'/PDMR Shareholdings
5th Feb 20247:00 amRNSNext Generation IHPS Delivery Order
30th Jan 20241:00 pmRNSDirector/PDMR Shareholding
26th Jan 20242:00 pmRNSResult of AGM
26th Jan 20247:00 amRNSAGM Trading Update
25th Jan 20243:00 pmRNSPDMR Shareholdings
24th Jan 20247:00 amRNSU.S. Defense Logistics Agency helmet order
15th Jan 20247:00 amRNSGerman Navy underwater rebreather contract
11th Jan 20244:00 pmRNSDirectors'/PDMR Shareholdings
4th Jan 20247:00 amRNSNotice of Capital Markets Event
21st Dec 20233:00 pmRNSHolding(s) in Company
14th Dec 202310:00 amRNSPDMRs’ Interest in Shares
12th Dec 20233:00 pmRNSNotice of Annual Report, Accounts and 2024 AGM
7th Dec 20239:28 amRNSDirector/PDMR Shareholding
27th Nov 20239:00 amRNSHolding(s) in Company
23rd Nov 20236:00 pmRNSDirector/PDMR Shareholding
23rd Nov 202312:00 pmRNSDirector/PDMR Shareholding
23rd Nov 202312:00 pmRNSDirector/PDMR Shareholding
21st Nov 20232:00 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSPreliminary Results
7th Nov 20234:00 pmRNSDirector/PDMR Shareholding
20th Oct 20233:00 pmRNSNotification of PDMR Dealing
20th Oct 20231:00 pmRNSDirector/PDMR Shareholding
18th Oct 20236:00 pmRNSDirector/PDMR Shareholding
17th Oct 20233:00 pmRNSDirector/PDMR Shareholding
17th Oct 20233:00 pmRNSDirector/PDMR Shareholding
13th Oct 20237:00 amRNSTrading Update & Restatement of FY22 Results
6th Oct 20231:00 pmRNSDirectors'/PDMR Shareholdings
21st Aug 20233:00 pmRNSInterim Dividend Currency Exchange Rate
8th Aug 20231:00 pmRNSDirector/PDMR Shareholding
25th Jul 20232:00 pmRNSHolding(s) in Company
19th Jul 20234:00 pmRNSHolding(s) in Company
14th Jul 202312:00 pmRNSDirector/PDMR Shareholding
10th Jul 202312:00 pmRNSDirector/PDMR Shareholding
10th Jul 20238:00 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSU.S. Army Next-Generation Ballistic Helmet Order
27th Jun 20235:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.